NDP
NDP (norrin cystine knot growth factor NDP, also known as norrin or EVR2) is a secreted cystine-knot protein that activates the canonical Wnt/beta-catenin pathway. It acts as a ligand for FZD4 and has a central role in retinal vascularisation. Browse Assay Genie's current range of NDP research reagents below, or read on for the biology behind the target.
NDP encodes norrin, a secreted protein with a cystine-knot motif that activates the canonical Wnt signalling pathway through FZD4 and the LRP5 coreceptor. By acting as a ligand for FZD4, norrin stabilises beta-catenin (CTNNB1) and activates LEF/TCF-mediated transcriptional programmes, and this signalling plays a central role in retinal vascularisation.
Norrin acts in concert with TSPAN12 to activate FZD4 independently of Wnt-dependent activation of FZD4. This suggests the existence of a Wnt-independent signalling route that also promotes accumulation of beta-catenin. The protein forms disulfide-linked oligomers in the extracellular matrix. UniProt also notes that it may be involved in a pathway regulating neural cell differentiation and proliferation, and that it may have a role in neuroectodermal cell-cell interaction.
HGNC classes the NDP gene among receptor ligands. The mouse ortholog is Ndp. Previous names, exudative vitreoretinopathy 2 (X-linked) and Norrie disease (pseudoglioma), reflect the disease association: mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. Researchers studying the NDP gene or norrin protein often focus on FZD4 signalling, beta-catenin regulation and retinal vascular development.
Norrin is a ligand for FZD4 and plays a central role in retinal vascularisation through beta-catenin signalling.
NDP activates the canonical Wnt pathway via FZD4 and LRP5, stabilising CTNNB1 and driving LEF/TCF-mediated transcription.
Mutations in NDP result in Norrie disease and X-linked exudative vitreoretinopathy, making it a focus for inherited retinal disorder studies.
Norrin may be involved in pathways regulating neural cell differentiation and proliferation, and possibly neuroectodermal cell-cell interaction.
NDP encodes norrin, a secreted ligand that activates canonical Wnt signalling through FZD4 and the LRP5 coreceptor. This stabilises beta-catenin and activates LEF/TCF-mediated transcription, a pathway that plays a central role in retinal vascularisation. It also acts with TSPAN12 to activate FZD4.
NDP is also called norrin and EVR2, and the UniProt protein name is Norrin. Earlier HGNC names were exudative vitreoretinopathy 2 (X-linked) and Norrie disease (pseudoglioma), both of which reflect the diseases linked to mutations in the gene.
Mutations in NDP result in Norrie disease and X-linked exudative vitreoretinopathy. The gene has a mouse ortholog, Ndp. Check the datasheet of any product for its validated reactivity before using it with a particular species.
Receptor, coreceptor and pathway partners of norrin in Wnt/beta-catenin signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q00604; product specifications from Assay Genie datasheets.